111 related articles for article (PubMed ID: 10482474)
1. Expression of transforming growth factor-beta superfamily receptors in developing rat eyes.
Yamada H; Obata H; Kaji Y; Yamashita H
Jpn J Ophthalmol; 1999; 43(4):290-4. PubMed ID: 10482474
[TBL] [Abstract][Full Text] [Related]
2. Expression of transforming growth factor-beta superfamily receptors in rat eyes.
Obata H; Kaji Y; Yamada H; Kato M; Tsuru T; Yamashita H
Acta Ophthalmol Scand; 1999 Apr; 77(2):151-6. PubMed ID: 10321529
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional evidence for a singular repertoire of BMP receptor signal transducing proteins in the lophotrochozoan Crassostrea gigas suggests a shared ancestral BMP/activin pathway.
Herpin A; Lelong C; Becker T; Rosa F; Favrel P; Cunningham C
FEBS J; 2005 Jul; 272(13):3424-40. PubMed ID: 15978047
[TBL] [Abstract][Full Text] [Related]
4. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.
Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P
J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014
[TBL] [Abstract][Full Text] [Related]
5. BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis.
Hanada K; Solchaga LA; Caplan AI; Hering TM; Goldberg VM; Yoo JU; Johnstone B
J Cell Biochem; 2001 Mar; 81(2):284-94. PubMed ID: 11241668
[TBL] [Abstract][Full Text] [Related]
6. Characterization of type I receptors for transforming growth factor-beta and activin.
ten Dijke P; Yamashita H; Ichijo H; Franzén P; Laiho M; Miyazono K; Heldin CH
Science; 1994 Apr; 264(5155):101-4. PubMed ID: 8140412
[TBL] [Abstract][Full Text] [Related]
7. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs.
Liu F; Ventura F; Doody J; Massagué J
Mol Cell Biol; 1995 Jul; 15(7):3479-86. PubMed ID: 7791754
[TBL] [Abstract][Full Text] [Related]
8. Effects of transforming growth factor beta on corneal epithelial and stromal cell function in a rat wound healing model after excimer laser keratectomy.
Mita T; Yamashita H; Kaji Y; Obata H; Yamada H; Kato M; Hanyu A; Suzuki M; Tobari I
Graefes Arch Clin Exp Ophthalmol; 1998 Nov; 236(11):834-43. PubMed ID: 9825259
[TBL] [Abstract][Full Text] [Related]
9. Expression of TGF-beta type I and type II receptors in rat eyes.
Obata H; Kaburaki T; Kato M; Yamashita H
Curr Eye Res; 1996 Mar; 15(3):335-40. PubMed ID: 8654115
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins and growth and differentiation factors in the human cornea.
You L; Kruse FE; Pohl J; Völcker HE
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):296-311. PubMed ID: 9950587
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of mRNA for transforming growth factor beta (TGF beta) and TGF beta receptors I and II and decreased TGF beta binding to the receptors in in vitro-aged fibroblasts.
Mori Y; Hatamochi A; Arakawa M; Ueki H
Arch Dermatol Res; 1998 Mar; 290(3):158-62. PubMed ID: 9558492
[TBL] [Abstract][Full Text] [Related]
13. The p21(RAS) farnesyltransferase alpha subunit in TGF-beta and activin signaling.
Wang T; Danielson PD; Li BY; Shah PC; Kim SD; Donahoe PK
Science; 1996 Feb; 271(5252):1120-2. PubMed ID: 8599089
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
[TBL] [Abstract][Full Text] [Related]
15. Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function.
Franzén A; Piek E; Westermark B; ten Dijke P; Heldin NE
Endocrinology; 1999 Sep; 140(9):4300-10. PubMed ID: 10465304
[TBL] [Abstract][Full Text] [Related]
16. Expression of TGF-beta superfamily receptors in dental pulp.
Toyono T; Nakashima M; Kuhara S; Akamine A
J Dent Res; 1997 Sep; 76(9):1555-60. PubMed ID: 9294489
[TBL] [Abstract][Full Text] [Related]
17. Regulation mechanisms of retinal pigment epithelial cell migration by the TGF-beta superfamily.
Mitsuhiro MR; Eguchi S; Yamashita H
Acta Ophthalmol Scand; 2003 Dec; 81(6):630-8. PubMed ID: 14641267
[TBL] [Abstract][Full Text] [Related]
18. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.
Inman GJ; Nicolás FJ; Callahan JF; Harling JD; Gaster LM; Reith AD; Laping NJ; Hill CS
Mol Pharmacol; 2002 Jul; 62(1):65-74. PubMed ID: 12065756
[TBL] [Abstract][Full Text] [Related]
19. Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.
Ebner R; Chen RH; Lawler S; Zioncheck T; Derynck R
Science; 1993 Nov; 262(5135):900-2. PubMed ID: 8235612
[TBL] [Abstract][Full Text] [Related]
20. Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors.
ten Dijke P; Miyazono K; Heldin CH
Curr Opin Cell Biol; 1996 Apr; 8(2):139-45. PubMed ID: 8791413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
